rss
Heart 2001;85:104-112 doi:10.1136/heart.85.1.104
  • Education in Heart
  • CORONARY DISEASE

Acute myocardial infarction: failed thrombolysis

  1. Mark A de Belder
  1. South Cleveland Hospital, Middlesbrough, UK
  1. Dr MA de Belder, South Cleveland Hospital, Marton Road, Middlesbrough TS4 3BW, UKmdb.sch.heart{at}onyxnet.co.uk

    Reperfusion strategies in the early phase of treatment of acute myocardial infarction aim to rapidly normalise and maintain tissue perfusion. Primary angioplasty is probably the best current treatment but it can only be applied to a minority of patients and has its own problems. Thrombolysis remains the most commonly used treatment. It has well demonstrated benefits, saving lives and reducing left ventricular damage, but is far from perfect.1 The mega-trials have sent a clear message that the greatest benefits are seen with patients who are treated early. Clinical efforts have therefore been concentrated on educating the population to heed the early symptoms, encouraging rapid admission to hospital (sometimes with thrombolytic treatment being administered in the ambulance) and minimising “door to needle” times. Continuous and widespread use of audit increases the number of patients treated and the speed with which treatment is administered.

    Key points

    • Failure of thrombolytic treatment at 1–2 hours is associated with a 30 day mortality > 15%

    • The diagnosis of failed thrombolytic treatment is currently best achieved with repeat 12 lead ECGs

    • The absence of chest pain 1–2 hours after the onset of thrombolytic treatment does not imply reperfusion

    • Conversely, the presence of chest pain does not imply failure to achieve TIMI-3 flow at coronary angiography

    • Angiographic coronary patency at 60–90 minutes is achieved more frequently after t-PA or r-PA compared with streptokinase, but there is no significant difference in vessel patency at 6–12 hours between these agents

    • Angiographic TIMI-3 flow is achieved in only 25–50% of patients with modern thrombolytic agents at 90 minutes after onset of treatment

    • Normal tissue perfusion is achieved in < 40% of patients treated with current thrombolytic agents

    • Repeat thrombolysis has not been shown to reduce mortality associated with failure of initial treatment

    • Rescue angioplasty has been shown to confer …

    Latest from Education in Heart

    Latest from Education in Heart

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.